Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04091126
Title Bortezomib, Lenalidomide and Dexamethasone (VRd) With Belantamab Mafodotin Versus VRd Alone in Transplant Ineligible Multiple Myeloma
Acronym DREAMM 9
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors GlaxoSmithKline
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | POL | ITA | GBR | FRA | ESP | DEU | CAN | AUS

Facility Status City State Zip Country Details
GSK Investigational Site WITHDRAWN Yuma Arizona 85364 United States Details
GSK Investigational Site RECRUITING Westwood Kansas 66205 United States Details
GSK Investigational Site RECRUITING Charlotte North Carolina 28204 United States Details
GSK Investigational Site WITHDRAWN Winston-Salem North Carolina 27157 United States Details
GSK Investigational Site RECRUITING Madison Wisconsin 53792 United States Details
GSK Investigational Site RECRUITING Waratah New South Wales 2298 Australia Details
GSK Investigational Site WITHDRAWN Clayton Victoria 3168 Australia Details
GSK Investigational Site RECRUITING Fitzroy Victoria 3065 Australia Details
GSK Investigational Site RECRUITING Edmonton Alberta T6G 1Z2 Canada Details
GSK Investigational Site COMPLETED London Ontario N6A 5W9 Canada Details
GSK Investigational Site WITHDRAWN Ottawa Ontario K1H 8L6 Canada Details
GSK Investigational Site WITHDRAWN Nantes cedex 1 44093 France Details
GSK Investigational Site RECRUITING Poitiers cedex 86021 France Details
GSK Investigational Site WITHDRAWN Rennes cedex 9 35033 France Details
GSK Investigational Site RECRUITING Heidelberg Baden-Wuerttemberg 69120 Germany Details
GSK Investigational Site RECRUITING Tuebingen Baden-Wuerttemberg 72076 Germany Details
GSK Investigational Site COMPLETED Schwerin Mecklenburg-Vorpommern 19049 Germany Details
GSK Investigational Site RECRUITING Koblenz Rheinland-Pfalz 56068 Germany Details
GSK Investigational Site RECRUITING Dresden Sachsen 01307 Germany Details
GSK Investigational Site RECRUITING Hamburg 20246 Germany Details
GSK Investigational Site RECRUITING Bologna Emilia-Romagna 40138 Italy Details
GSK Investigational Site RECRUITING Meldola Emilia-Romagna 47014 Italy Details
GSK Investigational Site RECRUITING Roma Lazio 00161 Italy Details
GSK Investigational Site WITHDRAWN Milano 20122 Italy Details
GSK Investigational Site RECRUITING Seoul, Korea 137-701 Korea, Republic of Details
GSK Investigational Site RECRUITING Seoul 03080 Korea, Republic of Details
GSK Investigational Site RECRUITING Seoul 03722 Korea, Republic of Details
GSK Investigational Site RECRUITING Seoul 06351 Korea, Republic of Details
GSK Investigational Site RECRUITING Lublin 20-081 Poland Details
GSK Investigational Site COMPLETED Poznan 61-848 Poland Details
GSK Investigational Site RECRUITING Badalona 08916 Spain Details
GSK Investigational Site RECRUITING Barcelona 08036 Spain Details
GSK Investigational Site RECRUITING Madrid 28027 Spain Details
GSK Investigational Site RECRUITING Málaga 29010 Spain Details
GSK Investigational Site RECRUITING Pamplona 31008 Spain Details
GSK Investigational Site RECRUITING Pozuelo De Alarcón/Madrid 28223 Spain Details
GSK Investigational Site RECRUITING Santander 39008 Spain Details
GSK Investigational Site COMPLETED Southampton Hampshire SO16 6YD United Kingdom Details
GSK Investigational Site RECRUITING Headington, Oxford OX3 7LE United Kingdom Details
GSK Investigational Site RECRUITING Leicester LE1 5WW United Kingdom Details
GSK Investigational Site RECRUITING London SE1 9RT United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field